Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 - Concepedia

Concepedia

Publication | Open Access

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

DOI Full Paper Access

495

Citations

15

References

2018

Year

Yu Jeong Bang, Eduardo Yañez Ruiz, Eric Van Cutsem, Kuhn‐Uk Lee, Lucjan Wyrwicz, Michael Schenker, María Alsina, Min‐Hee Ryu, Hyun Cheol Chung, Ludovic Evesque,

Annals of Oncology

References

	Year	Citations

Page 1